Thermo Fisher Scientific (TMO) is Resumed by JP Morgan to Overweight, Price Target at $180

Thermo Fisher Scientific (TMO) was Resumed by JP Morgan to “Overweight” and the brokerage firm has set the Price Target at $180. JP Morgan advised their investors in a research report released on Sep 22, 2016.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Thermo Fisher Scientific was Downgraded by Cleveland Research to ” Neutral” on Sep 9, 2016.

On the company’s financial health, Thermo Fisher Scientific reported $2.03 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $2.01. The company had revenue of $4535.20 million for the quarter, compared to analysts expectations of $4493.28 million. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 EPS.

Thermo Fisher Scientific opened for trading at $151.37 and hit $152.53 on the upside on Tuesday, eventually ending the session at $151.62, with a gain of 1.08% or 1.62 points. The heightened volatility saw the trading volume jump to 14,88,167 shares. Company has a market cap of $59,778 M.

In a different news, on Sep 6, 2016, Marc N Casper (Chief Executive Officer) sold 28,797 shares at $151.01 per share price. According to the SEC, on Aug 31, 2016, Daniel P Shine (Senior Vice President) sold 1,699 shares at $152.28 per share price. On Aug 31, 2016, Thomas W Loewald (Senior Vice President) sold 3,256 shares at $152.28 per share price, according to the Form-4 filing with the securities and exchange commission.

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Thermo Fisher Scientific

Leave a Reply

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.